Leukaemia, Myelocytic, Acute
Showing 1 - 4 of 4
Leukaemia, Myelocytic, Acute Trial in Australia, Canada, United States (GSK2879552, ATRA)
Terminated
- Leukaemia, Myelocytic, Acute
-
Augusta, Georgia
- +7 more
Apr 2, 2019
Leukaemia, Myelocytic, Acute Trial in France, Germany, United States (GSK Biologicals' recombinant WT1 Antigen-Specific Cancer
Completed
- Leukaemia, Myelocytic, Acute
- GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI) GSK2130579A
-
Baltimore, Maryland
- +21 more
Jun 27, 2018
Leukaemia, Myelocytic, Acute Trial in France, United States (GSK Biologicals' recombinant WT1 Antigen-Specific Cancer
Completed
- Leukaemia, Myelocytic, Acute
- GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI)
-
Tampa, Florida
- +9 more
Jan 8, 2018
Leukaemia, Myelocytic, Acute Trial in Nashville, San Antonio (GSK1120212, Gemcitabine)
Completed
- Leukaemia, Myelocytic, Acute
-
Nashville, Tennessee
- +1 more
Nov 8, 2017